Correlation Between SurModics and Neuroone Medical

Can any of the company-specific risk be diversified away by investing in both SurModics and Neuroone Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SurModics and Neuroone Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SurModics and Neuroone Medical Technologies, you can compare the effects of market volatilities on SurModics and Neuroone Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SurModics with a short position of Neuroone Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SurModics and Neuroone Medical.

Diversification Opportunities for SurModics and Neuroone Medical

-0.73

Correlation Coefficient

SurModics  Neuroone Medical

Pay attention - limited upside

The 3 months correlation between SurModics and Neuroone is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding SurModics and Neuroone Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuroone Medical Tec and SurModics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SurModics are associated (or correlated) with Neuroone Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuroone Medical Tec has no effect on the direction of SurModics i.e., SurModics and Neuroone Medical go up and down completely randomly.

Pair Corralation between SurModics and Neuroone Medical

Given the investment horizon of 90 days SurModics is expected to generate 0.57 times more return on investment than Neuroone Medical. However, SurModics is 1.75 times less risky than Neuroone Medical. It trades about 0.03 of its potential returns per unit of risk. Neuroone Medical Technologies is currently generating about 0.01 per unit of risk. If you would invest  3,361  in SurModics on September 22, 2024 and sell it today you would earn a total of  614.00  from holding SurModics or generate 18.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SurModics  vs.  Neuroone Medical Technologies

SurModics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SurModics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, SurModics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Neuroone Medical Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuroone Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with SurModics and Neuroone Medical

The main advantage of trading using opposite SurModics and Neuroone Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SurModics position performs unexpectedly, Neuroone Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuroone Medical will offset losses from the drop in Neuroone Medical's long position.

The idea behind SurModics and Neuroone Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.